Breakthrough for deep tech in Sri Lanka, Jendo closes new investment round

WHAT began as a university project over a decade ago has evolved into a groundbreaking medical technology that could save millions of lives worldwide.

- 

Jendo Innovations, a Sri Lankan biomedical startup valued at over several million dollars, has developed as a groundbreaking Artificial Intelligence (Al)-powered device capable of detecting early-stage heart disease in just 15 minutes.

The breakthrough addresses a critical global health challenge; cardiovascular disease claims nearly 18 million lives annually, often striking without warning. Traditional diagnostic methods like angiograms and stress tests are invasive, expensive, and typically detect problems only after significant damage has occurred. Jendo’s breakthrough provides a comprehensive cardiovascular health report within minutes.

Jendo has successfully closed its latest investment round predominantly from US investors, marking a significant milestone in the company's growth trajectory. Under the leadership of Chairman/CEO Keerthi Kodithuwakku and the team, the company is now strategically positioning itself for entry into the US market, with FDA approval processes already underway.

The company is already preparing for its Series A funding round, planned for the beginning of next year, which will fuel further international expansion and regulatory approvals.